Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 20, 2009 16:05 ET | Source: MDRNA, Inc.

MDRNA, Inc. to Hold Year-End 2008 Earnings Conference on Tuesday, March 24, 2009, at 8:30 a.m. Eastern Time

BOTHELL, WA--(Marketwire - March 20, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it will host a conference call with investors and security analysts on Tuesday, March 24, 2009, at 8:30...
March 06, 2009 08:30 ET | Source: MDRNA, Inc.

MDRNA, Inc. Receives Delisting Notice From NASDAQ and Requests Hearing

BOTHELL, WA--(Marketwire - March 6, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it received a NASDAQ Staff Determination on March 4, 2009 indicating that the Company has not regained...
February 23, 2009 08:30 ET | Source: MDRNA, Inc.

MDRNA Successfully Silences Gene Targets in Animal Models Using Novel UsiRNA Constructs

BOTHELL, WA--(Marketwire - February 23, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today positive in vivo efficacy data on its proprietary UsiRNA constructs demonstrating a dose response which...
February 13, 2009 08:30 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Licensing Agreement With Roche

BOTHELL, WA--(Marketwire - February 13, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today that it has entered into an agreement with Roche (SWX: ROG) in which Roche will obtain a non-exclusive...
February 03, 2009 09:25 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Receipt of Milestone Payment Under Amended Agreement With Amylin Pharmaceuticals, Inc. for Development and Commercialization of Intranasal Exenatide

BOTHELL, WA--(Marketwire - February 3, 2009) - MDRNA, Inc. (NASDAQ: MRNA) announced today the achievement of a milestone under an amended version of the June 2006 Development and License Agreement...
December 15, 2008 09:18 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Tentative FDA Approval of Generic Calcitonin-Salmon Nasal Spray for Osteoporosis

BOTHELL, WA--(Marketwire - December 15, 2008) - MDRNA, Inc. (NASDAQ: MRNA) announced today that the U.S. Food and Drug Administration (FDA) has granted tentative approval of MDRNA's Abbreviated New...
December 03, 2008 08:00 ET | Source: MDRNA, Inc.

MDRNA Reports UNA-Modified siRNAs Effectively Silence Gene Targets in Animal Models

BOTHELL, WA--(Marketwire - December 3, 2008) - MDRNA, Inc. (NASDAQ: MRNA) announced today positive in vivo efficacy data on its proprietary Unlocked Nucleic Acid (UNA) siRNAs in animal models,...
November 25, 2008 08:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. to Present at Piper Jaffray Healthcare Conference

BOTHELL, WA--(Marketwire - November 25, 2008) - MDRNA, Inc. (NASDAQ: MRNA) announced today that J. Michael French, President and CEO, will present at the Piper Jaffray Healthcare Conference on...
November 24, 2008 16:01 ET | Source: MDRNA, Inc.

MDRNA, Inc. Receives NASDAQ Notification

BOTHELL, WA--(Marketwire - November 24, 2008) - MDRNA, Inc. (NASDAQ: MRNA) announced today that on November 18, 2008 it received a letter from The NASDAQ Stock Market, Inc. notifying the Company...
November 13, 2008 16:00 ET | Source: MDRNA, Inc.

MDRNA, Inc. Announces Third Quarter 2008 Financial Results

BOTHELL, WA--(Marketwire - November 13, 2008) - MDRNA, Inc. (NASDAQ: MRNA) today reported financial results for the three- and nine-month periods ended September 30, 2008. Revenue for the three...